System for generating high concentration factors for low cell density suspensions

Patent metadata

Field	Value
Publication number	US-10308928-B2
Application number	US-201715690190-A
Country	US
Kind code	B2
Filing date	Aug 29, 2017
Priority date	Sep 13, 2013
Publication date	Jun 4, 2019
Grant date	Jun 4, 2019

Abstract

Acoustophoretic devices and methods for concentrating targeted biological cells in a reduced volume using multi-dimensional acoustic standing waves are disclosed. The methods include flowing a mixture of a host fluid and the biological cells through an acoustophoretic device. The acoustophoretic devices include an inlet, an outlet, and a flow chamber having an ultrasonic transducer-reflector pair. Biological cells, such as T cells, are separated from a host fluid for utilization in allergenic or autologous cell therapies. The disclosed devices and methods are capable of concentrating biological cells to at least 100 times their original cell concentration. The disclosed methods and devices are further capable of decreasing an original feed volume to a final concentrated volume that is less than one percent of the original feed volume.

First claim

The invention claimed is:

1. A method for concentrating target particles in a host fluid, comprising:
receiving an original concentration mixture of the host fluid and the target particles in an acoustophoretic device, the acoustophoretic device comprising:
an acoustic chamber with an inlet;
at least one ultrasonic transducer coupled to the acoustic chamber, the at least one ultrasonic transducer configured to launch an acoustic wave in the acoustic chamber; and

a collector with at least one angled wall that taper downwards in a cross-sectional area located between the inlet and the at least one ultrasonic transducer;
exciting the at least one ultrasonic transducer to launch the acoustic wave in the acoustic chamber; and
concentrating the target particles via the acoustic wave by at least an order of magnitude difference from the original concentration mixture.

2. The method of claim 1 , further comprising concentrating the target particles to a final concentration of about 150 times to about 300 times the original concentration mixture.

3. The method of claim 1 , further comprising concentrating the target particles to a final concentration of about 300 times to about 600 times the original concentration mixture.

4. The method of claim 1 , wherein the target particles are cells with an original cell concentration of about 1 million cells per mL.

5. The method of claim 1 , further comprising recovering the target particles in a final concentrated volume from the acoustic chamber.

6. The method of claim 5 , wherein the total particle retention in the final concentrated volume is at least 80%.

7. The method of claim 1 , further comprising flowing the original concentration mixture vertically into the acoustic chamber.

8. The method of claim 1 , further comprising:
flowing the original concentration mixture into an inlet of the acoustophoretic device;
recovering a particle depleted permeate at a first outlet; and
recovering the concentrated target particles at a second outlet.

9. The method of claim 8 , further comprising collecting the concentrated target particles with the collector.

10. The method of claim 9 , further comprising flowing the original concentration mixture through an annular plenum around the collector.

11. The method of claim 9 , further comprising continuously trapping the target particles via the acoustic wave, such that the target particles agglomerate, aggregate, clump, or coalesce together, and settle out of the host fluid and into the collector.

12. The method of claim 1 , wherein the target particles are one or more of T-cells, B cells, or NK cells.

13. The method of claim 1 , further comprising reducing a turbidity of the host fluid by at least 65% after 60 minutes, or at least 70% after 60 minutes, or at least 80% after 60 minutes, or at least 90% after 60 minutes.

14. A method for obtaining concentrated target cells, comprising:
receiving an original feed volume of a mixture of a host fluid and the target cells in an acoustophoretic device, the acoustophoretic device comprising:
an acoustic chamber with an inlet;
at least one ultrasonic transducer coupled to the acoustic chamber, the at least one ultrasonic transducer configured to launch an acoustic wave in the acoustic chamber; and
a collector with at least one angled wall that tapers downwards in a cross-sectional area located between the inlet and the at least one ultrasonic transducer;

exciting the at least one ultrasonic transducer to launch the acoustic wave in the acoustic chamber; and
recovering at least 40% of the concentrated target cells in the original feed volume in a final concentrated volume via the acoustic wave, wherein the final concentrated volume is at least an order of magnitude smaller than the original feed volume.

15. The method of claim 14 , wherein the total target cell retention in the final concentrated volume is at least 80%.

16. The method of claim 14 , further comprising continuously trapping the target cells via the acoustic wave, such that the target cells agglomerate, aggregate, clump or coalesce together, and settle out of the host fluid.

17. The method of claim 14 , further comprising reducing a turbidity of the host fluid by at least 65% after 60 minutes, or at least 70% after 60 minutes, or at least 80% after 60 minutes, or at least 90% after 60 minutes.

18. A method for obtaining concentrated target cells, comprising:
receiving an original feed volume of a mixture of a host fluid and the target cells in an acoustophoretic device, the acoustophoretic device comprising:
an acoustic chamber with an inlet;
at least one ultrasonic transducer coupled to the acoustic chamber, the at least one ultrasonic transducer configured to launch an acoustic wave in the acoustic chamber; and
a collector with at least one angled wall that taper downwards in a cross-sectional area located between the inlet and the at least one ultrasonic transducer;

exciting the at least one ultrasonic transducer to generate the acoustic wave in the acoustic chamber;
concentrating the target cells via the acoustic standing wave; and
retaining at least 80% of the target cells from the original feed volume in a final concentrated volume.

Assignees

• Flodesign Sonics Inc

Inventors

• Lipkens Bart
• Dionne Jason
• Ghoshal Goutam

Classifications

• C12N13/00 Primary

  Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves · CPC title

• B01D21/283

  Settling tanks provided with vibrators · CPC title

• G10K15/00

  Acoustics not otherwise provided for · CPC title

• B06B1/0644

  using a single piezoelectric element (B06B1/0688 takes precedence) · CPC title

• B01D17/044

  by changing the pressure · CPC title